Biogen discontinues Alzheimer’s medication Aduhelm - CNN
Jan 31, 2024 · The Alzheimer’s medication Aduhelm is being discontinued by drugmaker Biogen as it shifts resources to its other Alzheimer’s medication, Leqembi, and developing other treatments, the company...
Biogen’s Decision to Discontinue Alzheimer’s Drug | alz.org
CHICAGO, Jan. 31, 2024 — Despite today’s announcement from Biogen, the Alzheimer’s Association is extremely optimistic about the future of Alzheimer’s treatments; a new era that started with the Food and Drug Administration (FDA) accelerated approval of Aduhelm in 2021.
Biogen to shut down controversial Alzheimer's drug Aduhelm | AP News
Jan 31, 2024 · Biogen will stop selling its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster that stumbled after its launch a few years ago. The drugmaker also said Wednesday that it will end a study of the drug needed for …
Biogen to Realign Resources for Alzheimer's Disease Franchise
Jan 31, 2024 · Company to reprioritize resources allocated to ADUHELM ® (aducanumab-avwa) to advance LEQEMBI ® (lecanemab-irmb) and to develop new treatment modalities. Biogen committed to building a leading Alzheimer’s disease franchise to address patient needs.
Biogen to stop selling controversial Alzheimer's drug Aduhelm - NBC News
Jan 31, 2024 · Biogen will stop developing its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster before stumbling soon after its launch a couple years ago.
Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelm
Jan 31, 2024 · The drug maker Biogen said on Wednesday it would abandon its ownership rights to Aduhelm, an Alzheimer’s drug that had provoked fierce criticism of the company and regulators after it was...
Biogen drops Alzheimer's drug Aduhelm, ending a 17-year chapter
Jan 31, 2024 · Biogen will end a post-approval study of Alzheimer's treatment Aduhelm and return the licensing rights on the drug after failing to find a partner to mitigate costs of obtaining standard...
Biogen Is Dropping Controversial Alzheimer's Drug Aduhelm - U.S. News …
WEDNESDAY, Jan. 31, 2024 (HealthDay News) -- Biogen, maker of the Alzheimer's medicine Aduhelm, announced Wednesday that it would "discontinue the development and commercialization" of the...
Biogen scraps controversial Alzheimer's drug Aduhelm - CBS News
Jan 31, 2024 · Biogen is pulling the plug on the controversial drug Aduhelm, the first drug cleared by government health officials for treating Alzheimer's in nearly two decades.
EU regulator rejects Biogen, Eisai’s Alzheimer's drug
Jul 26, 2024 · The Alzheimer's drug saw a surprise jump in sales in early 2024, with Biogen reporting that first-quarter global in-market sales of Leqembi were approximately $19 million. That was nearly triple ...